Papers
5
Total Citations
94
H-Index
5
About
Massimo Monturano is a leading researcher in oncological quality of life (QoL) and patient-reported outcomes, with a specific focus on post-surgical recovery trajectories in prostate and lung cancer. His work is distinguished by its rigorous application of psychometric validation and longitudinal modeling to understand how patients recover functionally and psychologically after robotic-assisted surgeries. Monturano led the validation of the Italian version of the EPIC-26 (20 citations) and the EORTC QLQ-C30 (15 citations), ensuring that these critical QoL instruments are reliable for Italian-speaking populations. His landmark study on prostate cancer patients (22 citations) identified distinct one-year recovery trajectories for urinary and sexual dysfunction, revealing that sociodemographic and medical factors can predict which patients will struggle most. He further developed a predictive nomogram for sexual function recovery after robot-assisted radical prostatectomy (18 citations), a tool with direct clinical utility. Extending his expertise to thoracic oncology, Monturano mapped one-year QoL trends after lung cancer lobectomy (19 citations), comparing robot-assisted and traditional approaches. Through these contributions, he has provided clinicians with evidence-based tools to anticipate patient needs and personalize post-operative care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5